Childhood obesity is a growing global health concern, leading to long-term physical and psychological problems. Understanding its causes can help parents, educators, and policymakers take preventive measures. Here are the 10 main causes of obesity in children: 1. Unhealthy Diet (Junk Food & Sugary Drinks) 2. Lack of Physical Activity 3. Genetic Factors 4. Psychological Factors … Read more
A recent study conducted by researchers at Osaka University’s Graduate School of Dentistry has uncovered a strong link between poor chewing habits and a higher risk of obesity in children. The findings highlight that how children chew and eat may be just as crucial as what they eat when it comes to preventing unhealthy weight … Read more
GLORY-1 is an innovative investigational therapy in the field of metabolic health, designed as a dual receptor agonist targeting both glucagon (GCG) and glucagon-like peptide-1 (GLP-1) receptors. Developed by Innovent Biologics, GLORY-1—also known by its research name, Mazdutide—aims to deliver superior efficacy for weight loss and metabolic improvements by combining the actions of these two … Read more
A landmark Phase 3 clinical study of mazdutide, the world’s first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, has been published in The New England Journal of Medicine (NEJM), signaling a pivotal advancement in the fight against obesity. The trial, known as GLORY-1, demonstrates the remarkable efficacy and safety of mazdutide in Chinese adults with … Read more
Hi, I’m Mila —a recovering stress-eater, snack procrastinator, and occasional breakfast skipper. For years, I cycled through phases of “eating clean,” only to fall face-first into a bag of chips by Wednesday. Sound familiar? Fed up with the rollercoaster, I decided to try something different: 30 days of brutally honest food journaling. No guilt, no rules—just … Read more
In the world of weight loss medications, Ozempic has gained a reputation as a game-changer. Originally developed to manage type 2 diabetes, Ozempic—alongside other GLP-1 receptor agonists like Wegovy and Mounjaro—has become a go-to option for people seeking to shed excess weight. However, while the drug’s success stories are widely shared, a lesser-known side effect … Read more
Tokyo, Japan – A groundbreaking study from the University of Tokyo reveals that obesity causes temporary, but not permanent, disruptions in the liver’s ability to adapt to starvation. Published in Science Signaling, the research provides crucial insights into metabolic resilience and opens new avenues for understanding obesity-related diseases. Key Findings Why This Matters The liver plays a central role in … Read more
